Won Jin Chang

462 total citations
27 papers, 353 citations indexed

About

Won Jin Chang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Won Jin Chang has authored 27 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Won Jin Chang's work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). Won Jin Chang is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Genomics and Diagnostics (6 papers). Won Jin Chang collaborates with scholars based in South Korea, United States and Ethiopia. Won Jin Chang's co-authors include Yeul Hong Kim, Keunchil Park, Yoon Ji Choi, Seung Tae Kim, Jin Seok Ahn, Jung Yong Hong, Moon Ki Choi, Joon Oh Park, Jong‐Mu Sun and Myung‐Ju Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Won Jin Chang

26 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Won Jin Chang South Korea	12	177	110	91	79	56	27	353
Sugganth Daniel United States	7	196 1.1×	96 0.9×	70 0.8×	62 0.8×	67 1.2×	26	313
Irène Jiménez France	10	100 0.6×	62 0.6×	39 0.4×	80 1.0×	29 0.5×	34	304
Anna Maria Elisabeth Walenkamp Netherlands	9	271 1.5×	68 0.6×	73 0.8×	117 1.5×	79 1.4×	17	467
W Schmiegel Germany	11	118 0.7×	63 0.6×	47 0.5×	59 0.7×	54 1.0×	25	294
A. Oltra Spain	11	237 1.3×	116 1.1×	83 0.9×	37 0.5×	104 1.9×	18	394
Vincent Verschaeve Belgium	9	112 0.6×	147 1.3×	59 0.6×	157 2.0×	29 0.5×	21	389
Hun-Mo Ryoo South Korea	10	102 0.6×	112 1.0×	47 0.5×	106 1.3×	53 0.9×	30	300
Johanna Wassermann France	12	197 1.1×	83 0.8×	98 1.1×	77 1.0×	43 0.8×	41	514
Fabrice Jardin France	9	81 0.5×	59 0.5×	58 0.6×	50 0.6×	110 2.0×	22	277
Robert Díaz Beveridge Spain	11	172 1.0×	139 1.3×	48 0.5×	35 0.4×	48 0.9×	43	317

Countries citing papers authored by Won Jin Chang

Since Specialization

Citations

This map shows the geographic impact of Won Jin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Jin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Jin Chang more than expected).

Fields of papers citing papers by Won Jin Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won Jin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Jin Chang. The network helps show where Won Jin Chang may publish in the future.

Co-authorship network of co-authors of Won Jin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Won Jin Chang. A scholar is included among the top collaborators of Won Jin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won Jin Chang. Won Jin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Ju Won, Hyo Jin Lee, Sook Ryun Park, et al.. (2024). Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). Journal for ImmunoTherapy of Cancer. 12(3). e008638–e008638. 4 indexed citations

Lee, Jong Won, Young Soo Park, Won Jin Chang, et al.. (2022). Genetic Characteristics Associated With Drug Resistance in Lung Cancer and Colorectal Cancer Using Whole Exome Sequencing of Cell-Free DNA. Frontiers in Oncology. 12. 843561–843561. 5 indexed citations

Choi, Sun-Ho, Minhyeok Lee, Young Soo Park, et al.. (2020). Clinical Implication of Concordant or Discordant Genomic Profiling between Primary and Matched Metastatic Tissues in Patients with Colorectal Cancer. Cancer Research and Treatment. 52(3). 764–778. 6 indexed citations

Chang, Won Jin, Jae Sook Sung, Sung Yong Lee, et al.. (2020). The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA. Journal of Clinical Medicine. 9(8). 2642–2642. 5 indexed citations

Yun, Young Ho, EunKyo Kang, Sohee Park, et al.. (2019). Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled Trial. Journal of Pain and Symptom Management. 58(6). 940–948.e2. 19 indexed citations

Kim, Moon Jin, Sung Min Kim, Hyun Ae Jung, et al.. (2018). Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. The Korean Journal of Internal Medicine. 34(5). 1107–1115. 2 indexed citations

Chang, Won Jin & Yeul Hong Kim. (2017). De novo EGFR T790M, KRAS and PIK3CA somatic mutations in cell free DNA in non-small cell lung cancer patients and clinical characteristics.. Journal of Clinical Oncology. 35(15_suppl). e20561–e20561. 1 indexed citations

Sung, Jae Sook, Nak‐Jung Kwon, Jong Won Lee, et al.. (2017). Detection of somatic variants and EGFR mutations in cell-free DNA from non-small cell lung cancer patients by ultra-deep sequencing using the ion ampliseq cancer hotspot panel and droplet digital polymerase chain reaction. Oncotarget. 8(63). 106901–106912. 18 indexed citations

Choi, Yoon Ji, Won Jin Chang, Sang Won Shin, et al.. (2016). The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer. OncoTargets and Therapy. 9. 3307–3307. 10 indexed citations

10.

Lee, Ji Yun, Won Jin Chang, Sung Hee Lim, et al.. (2016). MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. Oncotarget. 7(28). 43492–43503. 48 indexed citations

11.

Lee, Min‐Young, Won Jin Chang, Hae Su Kim, et al.. (2016). Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series. PLoS ONE. 11(9). e0163254–e0163254. 7 indexed citations

12.

Choi, Moon Ki, Jung Yong Hong, Won Jin Chang, et al.. (2015). A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test. Cancer Chemotherapy and Pharmacology. 75(6). 1229–1236. 7 indexed citations

13.

Kim, Seung Tae, Won Jin Chang, Lihua Jin, et al.. (2015). Can Serum be Used for Analyzing the <i>KRAS</i> Mutation Status in Patients with Advanced Colorectal Cancer?. Cancer Research and Treatment. 47(4). 796–803. 6 indexed citations

14.

Lee, Ji Yun, Sung Hee Lim, Sung‐Min Kim, et al.. (2014). Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?. Cancer Chemotherapy and Pharmacology. 73(5). 1063–1070. 19 indexed citations

15.

Chang, Won Jin, et al.. (2014). A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): Paclitaxel plus carboplatin versus vinorelbine plus cisplatin. Lung Cancer. 84(1). 51–55. 24 indexed citations

16.

Jung, Hyun Ae, Yeon Hee Park, Sung‐Min Kim, et al.. (2014). Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology. Tumor Biology. 36(2). 1073–1079. 11 indexed citations

17.

Park, Silvia, Su Jin Lee, Won Jin Chang, et al.. (2013). Positive Correlation between Baseline PET or PET/CT Findings and Clinical Parameters in Multiple Myeloma Patients. Acta Haematologica. 131(4). 193–199. 20 indexed citations

18.

Park, Silvia, Myung‐Ju Ahn, Jin Seok Ahn, et al.. (2013). A Prospective Phase II Trial of Induction Chemotherapy with Docetaxel/Cisplatin for Masaoka Stage III/IV thymic Epithelial Tumors. Journal of Thoracic Oncology. 8(7). 959–966. 34 indexed citations

19.

Lee, Suk‐young, Se Ryeon Lee, Won Jin Chang, et al.. (2012). Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. The Korean Journal of Hematology. 47(2). 150–150. 13 indexed citations

20.

Chang, Won Jin, Eun Joo Lee, Sang Yeub Lee, et al.. (2011). Successful salvage treatment of steroid‐refractory bronchiolar COP with low‐dose macrolides. Pathology International. 62(2). 144–148. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact